OH HB39 | 2007-2008 | 127th General Assembly
Status
Spectrum: Partisan Bill (Democrat 11-0)
Status: Introduced on February 20 2007 - 25% progression, died in committee
Action: 2007-02-20 - To Health
Pending: House Health Committee
Status: Introduced on February 20 2007 - 25% progression, died in committee
Action: 2007-02-20 - To Health
Pending: House Health Committee
Summary
To amend section 3715.99 and to enact sections 3715.88, 3715.89, and 3715.90 of the Revised Code to require manufacturers and labelers of dangerous drugs to disclose to the Director of Health the value, nature, and purpose of certain gifts, fees, payments, subsidies, and other economic benefits they provide in connection with pharmaceutical detailing, marketing, or promotion.
Title
Drug manufacturers-disclose marketing incentives
Sponsors
History
Date | Chamber | Action |
---|---|---|
2007-02-20 | To Health | |
2007-02-20 | Introduced to House |
Ohio State Sources
Type | Source |
---|---|
Summary | http://archives.legislature.state.oh.us/bills.cfm?ID=127_HB_39 |